文献速递临床生化临床免疫

单克隆丙种球蛋白病患者的25-羟基维生素D假性显著升高

Falsely markedly elevated 25-hydroxyvitamin D in patients with monoclonal gammopathies.
PubMed 文献 · Clin Chem Lab Med · 2020-10-30

该研究在4个月内观察到7例单克隆疾病患者使用Abbott免疫分析法测得25-羟基维生素D(25(OH)D)假性极度升高超过160 ng/mL(>400 nmol/L)。对50例已知单克隆疾病患者血清用Abbott Architect i2000和LC-MS/MS检测,发现8例Abbott分析仪假性升高,1例Siemens平台假性升高,Roche结果与LC-MS/MS可比。研究排除类风湿因子和异嗜性抗体为干扰原因,建议对高度升高结果稀释并换用LC-MS/MS复核。

要点

  • Abbott Architect分析仪检测单克隆疾病患者25(OH)D可能出现假性极度升高。
  • 高值结果应稀释,若稀释非线性应换用LC-MS/MS等不同方法复核。
  • 无已知单克隆疾病但25(OH)D假性升高者,可考虑请求蛋白电泳排除副蛋白干扰。

核心结论

  • 单克隆疾病患者使用Abbott Architect分析仪检测25(OH)D存在假性显著升高的风险。

研究设计与样本

  • 4个月内观察7例单克隆疾病患者出现25(OH)D假性极度升高超过160 ng/mL(>400 nmol/L)。
  • 对50例已知单克隆疾病患者血清用Abbott Architect i2000和LC-MS/MS检测25(OH)D。
  • 对假性升高样本另用Siemens和Roche平台分析。

主要发现

  • 50例中8例在Abbott分析仪出现25(OH)D假性升高,1例在Siemens平台假性升高。
  • Roche平台结果与LC-MS/MS可比。
  • 额外研究排除了类风湿因子和异嗜性抗体升高作为Abbott分析干扰原因。

关键数值与推荐

  • 假性极度升高定义为25(OH)D超过160 ng/mL(>400 nmol/L)。

临床怎么用

  • 对Abbott Architect分析仪检测的单克隆疾病患者25(OH)D高值结果应警惕假性升高。
  • 高度升高结果应稀释,若稀释非线性应换用不同方法(优选LC-MS/MS)复核。
  • 无已知单克隆疾病但25(OH)D假性升高者,实验室可考虑请求蛋白电泳排除副蛋白干扰。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Monoclonal immunoglobulins can cause interference in many laboratory analyses. During a 4 month period we observed seven patients with monoclonal disease and falsely extremely elevated 25-hydroxyvitamin D (25(OH)D) results above 160 ng/mL (>400 nmol/L) measured using an immunoassay from Abbott Diagnostics. Based on these findings, we studied the occurrence of falsely elevated 25(OH)D in samples with paraproteins and investigated possible mechanisms of the observed interference. METHODS: 25(OH)D was analyzed using the Architect i2000 platform from Abbott Diagnostics and a higher order method, liquid chromatography-mass spectrometry (LC-MS/MS), in serum samples from 50 patients with known monoclonal disease. Patients with falsely elevated 25(OH)D were included in further studies to elucidate the cause of interference. Spuriously elevated results were in addition analyzed on two alternative platforms (Siemens and Roche). RESULTS: Falsely elevated 25(OH)D levels were present in eight patients on the Abbott analyzer and one on the Siemens platform. Results from Roche were comparable with LC-MS/MS. Additional investigations excluded elevated concentrations of rheumatoid factor and heterophilic antibodies as the cause of interference in the Abbott assay. CONCLUSIONS: Laboratories should be aware of the risk of falsely elevated 25(OH)D in samples run on the Architect analyzer from patients with monoclonal disease. Highly elevated vitamin D results should be diluted and if the dilution is non-linear, rerun by a different method, preferably LC-MS/MS. In patients with spuriously elevated 25(OH)D without known monoclonal disease, the laboratory should consider requesting protein electrophoresis to exclude paraprotein interference.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Hager HB, Bolstad N, Warren DJ, et al. Falsely markedly elevated 25-hydroxyvitamin D in patients with monoclonal gammopathies. Clin Chem Lab Med. 2020. PMID: 33119540. doi:10.1515/cclm-2020-1411

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。